ABSTRACT To determine whether myocardial infarction could be detected early after onset by analysis of subforrns of the MM isoenzyme (isoforms) of creatine kinase (MM CK) in plasma, we subjected eight conscious dogs to coronary occlusion and quantified isoforms in serial plasma samples by chromatofocusing. minimum of 14.0 ± 4. 1% in 4.8 ± 1. 1 hr, and returned to baseline in 13.0 ± 2.9 hr after coronary occlusion. Total CK activity did not increase significantly until later, i.e., 5 hr after occlusion, and peaked at 1371 ± 530 IU/liter in 10.9 ± 1.9 hr. Within the first 4 hr after coronary occlusion, MMA consistently comprised more than 20% of plasma MM CK activity despite insignificant increase of total CK. Changes in isoform proportions were consistent and independent of peak total CK activity and of cumulative CK release over a 10-fold range. Thus initial CK release indicative of infarction is detectable within 1 hr after the onset of ischemia by quantification of plasma MM CK isoforms. Circulation 71, No. 2, 363-369, 1985. EARLY DIAGNOSIS and accurate timing of the onset of initial and recurrent myocardial infarction are useful for patient selection and assessment of interventions such as coronary thrombolysis designed to salvage jeopardized myocardium. ' The diagnosis of infarction is frequently established by detection of elevation of the MB isoenzyme of creatine kinase (CK) (EC 2.7.3.2) in plasma. Characterization of total CK and MB CK time-activity curves has been useful for estimation of infarct size.2A However, plasma CK activity does not generally exceed the normal range for several hours after the onset of ischemia. Furthermore, time- 
activity curves vary with infarct size so that early detection and timing of infarction are difficult to assess by analysis of CK activity alone.
Recently, subforms of individual isoenzymes of CK (isoforms) distinguished by differences in isoelectric points (pl) have been found in plasma after myocardial infarction.519 Isoforms in plasma were soon recognized to reflect not only the form released into plasma from tissue but also conversion of one form to another in plasma in vitro or in vivo.'0 Using a quantitative chromatofocusing assay that avoided intrapreparative denaturation, we have characterized the kinetics of conversion."' The isoform in either normal or necrotic myocardium was found to be MMA (p' = 7.91). The MMB (p' = 7.74) and MMc (pl = 7.51) isoforms evolved sequentially from MMA in a consistent, timedependent fashion in plasma in vitro and in vivo. These forms appear to correspond to those separated by isoelectric focusing (IEF) that have been designated with numerical subscripts, but differ in apparent isoelectric points: MMA corresponds to MM3 (p' = 6.86 by IEF'2); MMB corresponds to MM, (pl = 6.49); and MMC corresponds to MM, (pI -6.24).
Because the peak activity of tissue isoform in plasma after infarction has been found to occur several hours before the time of occurrence of peak total CK activity,' it seemed likely that changes in the relative proportions of isoforms in plasma after myocardial infarction might occur before total CK activity became significantly elevated. This study was performed to determine whether or not analysis of changes of MM CK isoform patterns after coronary arterial occlusion in conscious dogs facilitated early detection of infarction.
Methods
Animal preparations. Fifteen male mongrel dogs weighing 16 to 23 kg were anesthetized with pentobarbital (30 mg/kg iv), and a left thoracotomy was performed aseptically via the fifth intercostal space. A snare made from 20 pound test nylon line within a polyethylene (PE240) tube was looped around the left anterior descending or left circumflex coronary artery distal to the first major branch. Its end was coiled in a subcutaneous pocket and the chest was closed. An external jugular vein was catheterized with silicone rubber (Silastic) tubing filled with 1000 U/mI heparin. The distal end of the catheter was exteriorized posteriorly.
Seven days after surgery, when plasma total CK activity had returned to normal (<100 IU/liter), 250 ml of blood was obtained through the jugular venous catheter and stored at 40 C in fresh acid citrate dextrose (ACD) (15 ml/l00 ml blood of 80 mM sodium citrate, 35 mM citric acid, and 120 mM dextrose).
To avoid hypovolemia, an equal volume of saline was infused intravenously. Three days after collection of blood the dogs were supported in a sling, and electrocardiographic monitoring was initiated.
The coronary snare was exteriorized through a small incision, lidocaine (30 mg iv) was given, and the snare was tightened to produce coronary occlusion verified by ST segment changes. Lidocaine was administered as needed to control arrhythmias. The dogs showed no signs of distress or agitation after coronary occlusion and were returned to their cages within 3 hr. Heparinized blood samples (15 U/ml) were drawn immediately before coronary occlusion (time 0), hourly for 1 to 16 hr, every 2 hr until 24 hr, and 30, 36, and 48 hr after coronary occlusion. To maintain constant vascular volume, blood samples were replaced with equal volumes of filtered, citrated blood acquired previously from the same animal. Blood was drawn to clear the dead space of the venous catheter before acquisition of each sample. Samples were maintained at 40 C to preclude isoform conversion in vitro" and centrifuged immediately for 10 min at 1900 g. The plasma was supplemented with 5 mM 8-mercaptoethanol (final concentration). Total CK activity was measured and samples were stored at -700 C before isoform analysis. Autopsies were performed after each experiment. Recent myocardial infarction and complete coronary arterial occlusion were documented in each case.
Total CK activity and enzymatically estimated infarct size. Total CK activity was assayed spectrophotometrically at 370 C with a coupled enzyme system,'3 CK S.V.R. reagents (Calbiochem-Behring, La Jolla, CA), and aGEMENI miniature centrifugal analyzer (Electro-Nucleonics, Fairfield, NJ were pooled in filtration membrane cones (CF25; Amicon, Danvers, MA) and concentrated to 0.6 to 0.7 ml by centrifugation for 30 min at 950 g (4°C). The cones were washed three times with 100 ,ul of chromatofocusing equilibration buffer (pH 8.95 ) to recover virtually all of the CK activity and the total volume (< 1 ml) was applied to the chromatofocusing column.
Blue Sepharose chromatography and concentration of the sample removed 80% to 90% of the total protein in the plasma aliquot without appreciable loss of CK activity.
When total CK activity in the plasma sample was less than 100 IU/liter, a 10 to 15 ml aliquot of plasma was applied to an 80 ml Blue Sepharose column. The pH 8.2 eluent was passed through a 5 ml protein A Sepharose column (CL4B; Pharmacia, equilibrated with sodium phosphate buffer at pH 7.5 containing 2 mM /3-mercaptoethanol) to remove additional non-CK protein, primarily globulin.
CK fractions were pooled and concentrated in filtration membrane cones to a volume of less than 1 ml for chromatofocusing. Protein A Sepharose removed 50% to 60% of the non-CK protein remaining after Blue Sepharose chromatography. Recovery of CK activity exceeded 90% and was comparable for each MM CK isoform.
After reduction of the non-CK plasma proteins and concentration of the CK activity, pH of the sample was adjusted to 8.8 and the sample was applied to the chromatofocusing column as previously described." Fractions of each of the three MM CK isoforms were expressed as percentages of total MM CK activity in the original plasma sample. Because specific enzyme activity is the same for each MM isoform" and because the release of MB and BB CK from heart is minimal in dogs undergoing infarction,4 absolute enzyme activity of each MM isoform in the plasma sample was calculated by multiplying measured total CK activity by the percentage of MM CK attributable to each MM isoform.
Accuracy and precision. Hemodynamic changes associated with frequent blood sampling were minimized by concomitant infusion of equal volumes of autologous, whole blood anticoag-ulated with ACD. Because ACD binds calcium, we excluded possible effects of the concentrations of ACD in transfused blood on the rate of isoform conversion in vitro. Purified MMA CK was obtained from canine myocardium as previously described'5 and incubated at 37°C with canine plasma obtained before or 5 hr after coronary arterial occlusion. The 5 hr plasma sample was obtained after serial transfusions of ACD-treated blood (160 ml total volume). During 4 hr of incubation the proportions of isoforms in control plasma and in plasma containing ACD were indistinguishable.
To determine whether the Blue Sepharose or protein A Sepharose procedures affected proportions of isoforms detected in samples, plasma supplemented with known amounts of each of the three purified MM CK isoforms was applied to Blue Sepharose and protein A Sepharose columns. For both columns, the percentages of isoforms in the eluent were unchanged in comparison with values in the sample applied to the column. We have shown previously that chromatofocusing per se does not alfect isoform proportions. " 1 The reproducibility of the isoform analytical system combining chromatofocusing with one or both of the affinity chromatography steps was tested over several days by repeated analyses (two to five per sample) of samples with high (1260 lU/liter), moderate (623 IU/liter), or low (<100 IU/liter) CK activity.
Results
Among 15 dogs subjected to coronary arterial occlusion, five survived for at least 48 hr. Ten died because of ventricular fibrillation occurring 10 min to 17 hr after occlusion. Data from three dogs that died only after total CK activity had reached a maximum are included in the results. Complete coronary occlusion and recent myocardial infarction were verified at autopsy in each case.
The reproducibility of the isoform analyses was documented in repeated assays over several days of samples containing the entire range of total CK activities encountered in this study. Maximal differences encountered for the same sample analyzed sequentially were less than 5%. No isoform-specific differences were evident.
CK time-activity curves. Total CK activity in plasma samples before occlusion was consistently less than 100 IU/liter (62 + 16, range 46 to 90) and did not differ significantly from CK activity in separate, normal, unoperated dogs (69 + 22 IU/liter, n = 7). Total CK activity began to exceed 100 IU/liter (taken as the upper limit of normal based on the mean plus 2 SDs of values in samples from normal dogs) between 2 and 5 hr after coronary occlusion. Time-activity curves of total CK exhibited considerable but expected variation from dog to dog (figure 1) because of differences in the extent of infarction sustained. Thus MM CK isoform curves. In contrast to the absolute activities of individual MM CK isoforms, the timedependent changes in the relative proportions of isoforms were similar in each dog and independent of total CK activity ( figure 2 and table 2 The times to maximal portional values were ent to maximal total CK act release ( Our findirags indicate that proportions of MMA in plasma exceeding baseline (>20%) but associated with normal total CK activity (< 100 IU/liter) reflect an onset of infarction within 4 hr (table 1) . Conversely, baseline values of MMA associated with elevated total CK activity reflect an onset of infarction more than 14 hr previously ( figure 3 ). The combination of elevated MMA and elevated total CK reflects an onset of infarction within 2 to 14 hr. Marked MMA elevations (>40%) associated with increased total CK reflect an onset of infarction of 2 to 7 hr previously. With an onset of infarction more than 8 hr before acquisition of the blood sample, MMA was consistently less than 40% of total MM CK in each dog (figure 2). Thus analysis of MM CK isoforms and total CK activity in a single plasma sample provides an index of the time of onset of infarction.
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